Progesterone-induced blocking factor enhances pregnancy loss prediction in threatened miscarriage
Journal of Reproductive Immunology · 2026
DOI: 10.1016/j.jri.2026.104957 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Reproductive Immunology, 2026. Verfasst von Sifu Ha und 2 weiteren Autor:innen. Beteiligte Einrichtung: Reproductive Medicine Center, Dalian Women and Children's Medical Center (Group), No. 20 Baishan Road, Shahekou District, Dalian, Liaoning 116000, Ch…. Hauptthemen laut MEDLINE: Suppressor Factors, Immunologic, Pregnancy Proteins, Abortion, Threatened. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
Threatened miscarriage is common, and individualized risk stratification remains difficult when progesterone, beta-human chorionic gonadotropin, and ultrasound findings are discordant. This two-center retrospective prediction-model study evaluated whether progesterone-induced blocking factor (PIBF) adds prognostic information for early pregnancy loss before 16 gestational weeks. A total of 396 women were assigned to development (n = 182), internal validation (n = 78), and external validation (n = 136) cohorts. Development-only repeated cross-validation and a one-standard-error parsimony rule selected serum progesterone, fetal-heartbeat visibility, previous miscarriages, and log PIBF. Early pregnancy loss occurred in 45 (24.7%), 19 (24.4%), and 32 (23.5%) women, respectively. Compared with the three-variable conventional model, the PIBF-enhanced model increased the area under the receiver operating characteristic curve (AUC) in development (0.956 vs 0.901; P = 0.004), internal validation (0.942 vs 0.855; P = 0.009), and external validation (0.942 vs 0.813; P < 0.001). External bootstrap AUC was 0.942 (95% CI, 0.903-0.973), and the calibration slope was 0.971 (95% CI, 0.759-1.399). PIBF provided incremental prognostic information. The calculator is not a clinical decision tool without local recalibration. Larger independent external validation, treatment-confounding assessment, and assay standardization are also required before clinical use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Reproductive Medicine Center, Dalian Women and Children's Medical Center (Group), No. 20 Baishan Road, Shahekou District, Dalian, Liaoning 116000, China.
- Gynecology Clinic, Chunliu Campus, Dalian Women and Children's Medical Center (Group), No. 1 Dunhuang Road, Shahekou District, Dalian, Liaoning 116000, China.
- Reproductive Medicine Center, Dalian Women and Children's Medical Center (Group), No. 20 Baishan Road, Shahekou District, Dalian, Liaoning 116000, China. Electronic address: 18098858985@163.com.
Zitieren
APA
Ha, S., Ma, L., & Song, X. (2026). Progesterone-induced blocking factor enhances pregnancy loss prediction in threatened miscarriage. Journal of Reproductive Immunology. https://doi.org/10.1016/j.jri.2026.104957
Vancouver
Ha S, Ma L, Song X. Progesterone-induced blocking factor enhances pregnancy loss prediction in threatened miscarriage. Journal of Reproductive Immunology. 2026. doi:10.1016/j.jri.2026.104957
BibTeX
@article{Ha2026,
author = {Ha, Sifu and Ma, Lin and Song, Xiaoxia},
title = {Progesterone-induced blocking factor enhances pregnancy loss prediction in threatened miscarriage},
journal = {Journal of Reproductive Immunology},
year = {2026},
doi = {10.1016/j.jri.2026.104957}
}
EUVIMED